(Q34441079)

2 August 2017

1 reference

title

The role of tissue factor in the antiphospholipid syndrome (English)

1 reference

2 August 2017

Dobado-Berrios PM

1

1 reference

2 August 2017

López-Pedrera C

series ordinal

2

1 reference

2 August 2017

Velasco F

series ordinal

3

1 reference

2 August 2017

Cuadrado MJ

series ordinal

4

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

published in

Arthritis & Rheumatology

1 reference

2 August 2017

volume

44

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

2467-2476

1 reference

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

The antiphospholipid syndrome: ten years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Immunology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Interactions and molecular structure of cardiolipin and β2-glycoprotein 1 (β2-GP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Inhibition of phospholipid-dependent coagulation reactions by 'antiphospholipid antibodies': possible modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Determination of plasma tissue factor antigen and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Receptors for immunoglobulin G. Molecular diversity and implications for disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Soluble Fc gamma receptor III in human plasma originates from release by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

Antiphospholipid Syndrome in the Elderly: Caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200111%2944%3A11%3C2467%3A%3AAID-ART426%3E3.0.CO%3B2-U

10.1002/1529-0131(200111)44:11<2467::AID-ART426>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference